Nexus Biotech: The Newcastle Innovation You Need to Know About This Month

Nexus Biotech, which has quietly grown from a five-person startup in a Ouseburn warehouse three years ago, has just secured £12m in Series B funding and announced it's doubling its headcount to 80 by September. The firm, now based in a renovated Victorian building overlooking the Tyne, is developing AI-powered genetic analysis tools that help hospitals identify rare diseases faster—work that's caught the attention of NHS trusts across the region and beyond.

The company's timing is worth noting. As geopolitical tensions continue to reshape global supply chains and trade relationships, biotech firms like Nexus are being positioned as strategic assets for the UK's scientific independence. The firm currently processes genetic data for fourteen NHS hospitals, including Newcastle upon Tyne Hospitals NHS Trust, and has just begun pilot work with three European partners, suggesting ambitions to become a genuinely international player.

What makes Nexus locally significant isn't just the jobs or the funding—it's the ecosystem it's helping build. The company has partnered with Northumbria University's Advanced Computing Centre on Ellison Place to develop neural networks that can spot disease patterns humans might miss. That kind of university-industry collaboration has become increasingly rare outside London and the Golden Triangle, yet it's quietly flourishing here on Newcastle's Quayside.

The firm's co-founders were both Newcastle University graduates. One completed a PhD at the Centre for Life, the other spent five years working in the city's growing health tech sector before founding Nexus. They're now deliberately recruiting locally—current vacancies include bioinformaticians, software engineers, and lab technicians, with salaries ranging from £28,000 to £65,000 depending on experience. For a region still rebuilding its tech credentials after the decline of older industries, that's meaningful economic activity.

The broader context matters too. Newcastle's reputation as a tech hub has historically lagged Manchester and Leeds, but recent investments in the Quayside masterplan and the growth of firms like Nexus suggest something's shifting. The city now hosts over 2,300 tech companies, according to the latest Tech Nation report, employing roughly 8,500 people. It's not Silicon Valley, but it's no longer invisible either.

If you're tracking where British biotech innovation is heading outside the capital, Nexus Biotech deserves your attention. By autumn, this Tyne-side startup could be one of the North East's most strategically important companies—and most people still won't have heard of it.

This article was compiled by AI and screened before publishing. See our editorial standards.